Skip to main content
. 2024 Aug;30(8):883–896. doi: 10.18553/jmcp.2024.30.8.883

TABLE 1.

Patient Case Cost Breakdown by Cost-Shifting Strategy

Insurance type Month Manufacturer pays Insurance pays Patient pays a Maximum out-of-pocket remaining ($8,000 max)
Traditional, no manufacturer assistance January $0 $0 $2,000 $6,000
February $0 $0 $2,000 $4,000
March $0 $1,200 $800 $3,200
April $0 $1,200 $800 $2,400
May $0 $1,200 $800 $1,600
June $0 $1,200 $800 $800
July $0 $1,200 $800 $0
August $0 $2,000 $0 $0
September $0 $2,000 $0 $0
October $0 $2,000 $0 $0
November $0 $2,000 $0 $0
December $0 $2,000 $0 $0
Total $0 $16,000 $8,000
Traditional, with manufacturer assistance January $2,000 $0 $0 $6,000
February $2,000 $0 $0 $4,000
March $800 $1,200 $0 $3,200
April $800 $1,200 $0 $2,400
May $800 $1,200 $0 $1,600
June $800 $1,200 $0 $800
July $800 $1,200 $0 $0
August $0 $2,000 $0 $0
September $0 $2,000 $0 $0
October $0 $2,000 $0 $0
November $0 $2,000 $0 $0
December $0 $2,000 $0 $0
Total $8,000 $16,000 $0
Copay accumulator program January $2,000 $0 $0 $8,000
February $2,000 $0 $0 $8,000
March $2,000 $0 $0 $8,000
April $2,000 $0 $0 $8,000
May $0 $0 $2,000 $6,000
June $0 $0 $2,000 $4,000
July $0 $1,200 $800 $3,200
August $0 $1,200 $800 $2,400
September $0 $1,200 $800 $1,600
October $0 $1,200 $800 $800
November $0 $1,200 $800 $0
December $0 $2,000 $0 $0
Total $8,000 $8,000 $8,000
Copay maximizer program January $2,000 $0 $0 $8,000
February $2,000 $0 $0 $8,000
March $2,000 $0 $0 $8,000
April $2,000 $0 $0 $8,000
May $0 $2,000 $0 $8,000
June $0 $2,000 $0 $8,000
July $0 $2,000 $0 $8,000
August $0 $2,000 $0 $8,000
September $0 $2,000 $0 $8,000
October $0 $2,000 $0 $8,000
November $0 $2,000 $0 $8,000
December $0 $2,000 $0 $8,000
Total $8,000 $16,000 $0

Alternative funding plans were not included in this table because cost variations being assumed by the manufacturer or patients are directed to a specialty pharmacy outside of the United States.

a Commercial insurance with an annual deductible of $4,000, a maximum annual out-of-pocket limit of $8,000. After his deductible is met, the patient is responsible for 40% of the drug’s price (plan pays 60%).